A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients ( nts received G1 doses of30ug/kg/day w...)

HOME >> MEDICINE >> TECHNOLOGY

A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients

nts received G1 doses of 30ug/kg/day, while E1 doses started at 0.3ug/kg/day for most patients with some patients escalating to E1 doses of 0.5ug/kg/day or reducing to 0.2ug/kg/day. In the trial, 30 type 2 diabetes patients on oral anti-diabetic agents (metformin with/without TZD) were enrolled. These patients continued on their oral anti-diabetic medication for the duration of the trial. Upon entry into the trial, the patients' HbA1c levels ranged between 6.8% and 10.9%, with a mean HbA1c level of 8.1%. Transition reported interim unblinded data from this study in a press release dated March 5th, 2007.

About Transition

Transition is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets. Transition's lead products include regenerative therapies E1-I.N.T.(TM) and GLP1-I.N.T.(TM) for the treatment of diabetes and AZD-103/ELND-005 for the treatment of Alzheimer's disease. Transition has an emerging pipeline of preclinical drug candidates developed using its proprietary drug discovery engine. Transition's shares are listed on the Toronto Stock Exchange under the symbol "TTH". For additional information about the company, please visit www.transitiontherapeutics.com.

Notice to Readers: Information contained in our press releases should be considered accurate only as of the date of the release and may be superseded by more recent information we have disclosed in later press releases, filings with the OSC or otherwise. Except for historical information, this press release may contain forward-looking statements, relating to expectations, plans or prospects for Transition, including funding and conducting clinical trials. These statements are based upon the current expectations and beliefs of Transition's management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described
'"/>

Page: 1 2 3 4 5
Related medicine technology :

1. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
2. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
3. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
4. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
5. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
6. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
7. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
8. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
9. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
10. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
11. MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy

Post Your Comments:

(Date:5/21/2013)... TEANECK, N.J. , May 21, 2013 /PRNewswire-iReach/ ... 17-19 in NJ has attracted the greatest number ... reports its President, Mark Alexay ... "But suddenly everyone plans to attend this year. The show,s still ... of different companies. This is a big surprise ...

(Date:5/21/2013)... 2013 IsoRay, Inc. (AMEX: ISR ), ... into an exclusive international distribution agreement with IASIS Medical ... Greece . IsoRay is a medical ... radioisotope applications for brain cancer, lung cancer, head and ... IASIS Medical is ideally suited to support ...

(Date:5/21/2013)... 2013 The North Shore-LIJ Health System is expanding ... compliance at North Shore University Hospital in ... rooms at Forest Hills (NY) ... The new pilot program strengthens patient safety by providing ... the first time in the US that remote video ...

Breaking Medicine Technology:Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2 IsoRay Announces A New International Distributor For Greece 2 IsoRay Announces A New International Distributor For Greece 3 North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2 North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3 North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4

[0] Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show [0] IsoRay Announces A New International Distributor For Greece [0] North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs

... 2011 Reportlinker.com announces that a new market ... Global Ophthalmic Instrumentation Industry ... This report analyzes the worldwide markets for Ophthalmic ... by the following segments: Diagnostic Devices (Perimeters, Refractors, ...

... FREMONT, Calif., Feb. 2, 2011 WaferGen Biosystems, Inc. ... state-of-the-art genomic analysis systems, today announced that it will present an ... Investor Conference in New York City at the Waldorf Astoria Hotel, ... will be webcast live and archived for 90 days and may ...

Global Ophthalmic Instrumentation Industry WaferGen to Present at 13th Annual BIO CEO and Investor Conference

(Date:5/21/2013)... 22, 2013 Spring is the perfect ... farmers' markets filled with whole foods to weather perfect ... of the season the nutrition experts at Brilliant Nutrition ... to miss. , 1. Eating Locally, With the abundance ... to linger and explore, spring is a great time ...

(Date:5/21/2013)... 22, 2013 Feed additives have now ... industry value chain. Most of the feed additives are ... pellets, liquids, and powders. There are variety of feed ... concentrations depending upon the type of animal and feed. ... that provide essential nutrition to the animal in order ...

(Date:5/21/2013)... Daily Gossip Magazine published well-documented articles that are meant to ... on the latest weight loss methods by publishing weekly in-depth ... review of Kyle Leon’s Customized Fat Loss Plan ... lose weight or stay in shape with the minimum effort. ... by a popular fitness trainer, Kyle Leon, who has made ...

(Date:5/21/2013)... DISCcert has served the training industry ... 17 DISC applications at the July 25 & 26th ... The July 25 & 26th DISC certification in San ... applying DISC. The time-tested, proven support materials will include ... DISC training materials ; worksheets, handouts, learning activities, ...

(Date:5/21/2013)... 2013) Prostaglandin analogues (PGAs), drugs which lower intraocular ... people with glaucoma, but their use is not without ... dryness, changes in eye color and other side effects. ... also cause upper and lower eyelid drooping and other ... described in PLOS ONE . , Researchers from ...

Breaking Medicine News(10 mins):Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 2 Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 3 Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 2 Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 3 Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 4 Health News:Customized Fat Loss Plan Review and Diet Secrets Revealed By Daily Gossip Magazine 2 Health News:DISCcert Offers 17 Applications in Coming DISC Certification 2 Health News:DISCcert Offers 17 Applications in Coming DISC Certification 3 Health News:DISCcert Offers 17 Applications in Coming DISC Certification 4 Health News:Glaucoma drug can cause droopy eyelids 2

[0] Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring [0] Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com [0] Customized Fat Loss Plan Review and Diet Secrets Revealed By Daily Gossip Magazine [0] DISCcert Offers 17 Applications in Coming DISC Certification [0] Glaucoma drug can cause droopy eyelids

... new batch of video iPod repairs just announced at the website ipodjuice.com ... ... San Antonio, TX (PRWEB) November 30, 2008 -- With the 5th Generation ... LTD has added several new repair products and services to their website ...

... A major reform of the way that NHS hospitals ... in patient safety, according to research funded by the ... premiums to hospitals that meet certain targets has led ... academics from Nottingham, Oxford and Surrey universities looked at ...

... TALLAHASSEE, Fla., Nov. 29 Football fans may see an,unconventional ... Free,Florida will be tailgating under a tent, rooting for their ... The,unexpected twist is that the tailgaters are skeletons. The message ... tobacco." , (Photo: ...

... cold season , , SATURDAY, Nov. 29 (HealthDay News) -- Dry ... and develop dry patches, but there are a number of ... Moore, an instructor of pharmaceutics at the University of the ... constantly bombarded, dried out, and increasingly susceptible to infection," Moore ...

... Colorado,s upcoming statewide,Public Health Summit: From Vision to Action, is ... The event will bring together more than 300,stakeholders in public ... "The work at this ... has to do with delivery of basic health services," said ...

... centers aren,t catering to those with fewer resources , , FRIDAY, ... about 20 times more likely to donate a liver or ... says. , The national study by Harvard University researchers ... lacked health insurance at the time of hospitalization. , In ...

Cached Medicine News:Health News:Several New 5th Generation iPod Video Repairs Announced Today 2 Health News:Prescription for patient safety 2 Health News:Sudden Death Hits Stadiums Across Florida 2 Health News:Dry Skin? Don't Let Winter Win 2 Health News:Hundreds to Gather for Colorado Public Health Summit 2 Health News:Uninsured Likely Organ Donors, But Not Recipients 2

Several New 5th Generation iPod Video Repairs Announced Today Prescription for patient safety Sudden Death Hits Stadiums Across Florida Dry Skin? Don't Let Winter Win Hundreds to Gather for Colorado Public Health Summit Uninsured Likely Organ Donors, But Not Recipients

Straight shafts with rounded tips. Smooth handle with dull finish....

15 mm curved blade. 8 mm straight distal tip. Serrated on top of knife. Flat handle....

8 mm curved blade. Cutting edge on inside of curve. Flat handle....

... mm long blade. 17 mm ... mm, 12.0 inches. Note: Has ... left-hand cutting to any thickness ... mm). For thicker grafts or ...

Medicine Products:

McCullough Bipolar Forceps Colver Tonsil Knife And Dissector Canfield Tonsil Knife Blair-Brown Skin Graft Knife